Some mergers can add a nice shot in the arm for an acquirer. After years of being focused on Humira, AbbVie has now completed its acquisition of Allergan.
Tuesday's top analyst upgrades and downgrades included AbbVie, ANGI Homeservices, CBOE, Darden Restaurants, Hess, Lululemon Athletica, MongoDB, PayPal, Shopify, Slack and Zynga.
Wednesday's top analyst upgrades and downgrades included AbbVie, American Electric Power, Anheuser-Busch InBev, Arconic, Baidu, Best Buy, Co-Diagnostics, Cree, Exelon, Home Depot, NRG Energy, T-Mobile and Walmart.
Monday's top analyst upgrades and downgrades included AbbVie, Best Buy, Conagra Brands, Dick's Sporting Goods, General Motors, Hilton Worldwide, NetApp, Nvidia, Redfin, TJX Companies, Vale and Yelp.
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Monday's top analyst upgrades and downgrades included AbbVie, American Electric Power, ANGI Homeservices, DuPont, GileadSciences, Microsoft, Peloton Interactive, Shopify, Trivago and Walt Disney.
The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?
Monday's top analyst calls included AbbVie, AES, AT&T, Boeing, Carnival, CME, Coca-Cola, Comcast, Honeywell, Lululemon Athletica, Netflix, Shopify, Starbucks and Twitter.
The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical stocks decreased.
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Cree, Etsy, Gilead Sciences, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems and Virgin Galactic.
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks appear to be undervalued against the performance of the broader markets.
With even moderate appreciation in the share prices of these top companies, investors should be looking at double-digit total return potential. In a market that is very long in the tooth, that…
Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce.com, Tesla and Teva Pharmaceutical.
